- Home
- BIOA vs RCMT Comparison
BIOA vs RCMT Comparison
Compare BIOA & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIOA | RCMT |
|---|---|---|
| Founded | 2015 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.7M | 144.7M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | BIOA | RCMT |
|---|---|---|
| Price | $12.47 | $21.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $11.33 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 410.3K | 44.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | $5,917,000.00 | ★ $309,840,000.00 |
| Revenue This Year | N/A | $15.20 |
| Revenue Next Year | N/A | $7.50 |
| P/E Ratio | ★ N/A | $12.24 |
| Revenue Growth | N/A | ★ 13.70 |
| 52 Week Low | $2.88 | $13.18 |
| 52 Week High | $13.10 | $28.27 |
Technical Indicators
Market Signals| Indicator | BIOA | RCMT |
|---|---|---|
| Relative Strength Index (RSI) | 77.17 | 56.42 |
| Support Level | $12.00 | $20.59 |
| Resistance Level | $13.10 | $21.38 |
| Average True Range (ATR) | 0.72 | 0.77 |
| MACD | 0.26 | 0.32 |
| Stochastic Oscillator | 87.28 | 81.17 |
Price Performance
Historical ComparisonAbout BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.